Piedmont Neuropsychiatry is a clinical research site located in Charlotte, North Carolina, United States.
Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.
Piedmont Neuropsychiatry has participated in 5 clinical trials.
Therapeutic areas: Attention Deficit Hyperactivity Disorder (ADHD), ADHD, Attention Deficit Hyperactivity Disorder.
Sponsors: Shire, Cephalon, Epix Pharmaceuticals, Inc..
Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Piedmont Neuropsychiatry has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Piedmont Neuropsychiatry has 5 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder (ADHD), ADHD, Attention Deficit Hyperactivity Disorder.
Piedmont Neuropsychiatry has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.